Indian officials may intervene to assist Ranbaxy with managing FDA ban

NEW DELHI, India The Indian government may become a player in the dispute between the Food and Drug Administration and Ranbaxy Laboratories, according to India's Economic Times.

India's government will intervene if the FDA refuses to lift its ban on more than 30 drugs from Ranbaxy's Dewas and Paonta Sahib plants despite Ranbaxy's efforts to fix the manufacturing problems the regulatory agency identified earlier this month.